| Ivynnell Sandifer, MD | |
|
Banner Baywood Medical Center, 6644 E. Baywood Ave, Mesa, AZ 85206 | |
| (480) 981-2000 | |
| Not Available |
| Full Name | Ivynnell Sandifer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | Banner Baywood Medical Center, Mesa, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114958659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 24856 (Arizona) | Primary |
| Entity Name | Emergency Physicians Southwest Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912053752 PECOS PAC ID: 2264538529 Enrollment ID: O20070502000382 |
News Archive
Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, was presented with the 2010 Arthur Steindler Award at this week's annual meeting of the Orthopaedic Research Society in New Orleans.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
The E484K mutation has also been found on the B.1.351 and P.1 variant, contributing to their status as variants of concern. In February 2021, Public Health England published a report of 11 B.1.1.7 genomes that also had the E484K spike mutation. Currently, there are 247 isolates of B.1.1.7 + E484K reported globally, and new research finds the first reports of it in southeastern Pennsylvania.
New research published in the December issue of The Journal of the American College of Surgeons shows that outcomes of high-risk cancer operations in 80-year-olds are considerably worse than reported in case studies and published survival statistics, which may lead to unrealistic expectations about the safety of these operations in the elderly.
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at Case Western Reserve University and Johns Hopkins Medical Institutions shows.
› Verified 9 days ago
| Entity Name | Quantum Healthcare Medical Associates Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821391269 PECOS PAC ID: 5597946350 Enrollment ID: O20110228000065 |
News Archive
Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, was presented with the 2010 Arthur Steindler Award at this week's annual meeting of the Orthopaedic Research Society in New Orleans.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
The E484K mutation has also been found on the B.1.351 and P.1 variant, contributing to their status as variants of concern. In February 2021, Public Health England published a report of 11 B.1.1.7 genomes that also had the E484K spike mutation. Currently, there are 247 isolates of B.1.1.7 + E484K reported globally, and new research finds the first reports of it in southeastern Pennsylvania.
New research published in the December issue of The Journal of the American College of Surgeons shows that outcomes of high-risk cancer operations in 80-year-olds are considerably worse than reported in case studies and published survival statistics, which may lead to unrealistic expectations about the safety of these operations in the elderly.
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at Case Western Reserve University and Johns Hopkins Medical Institutions shows.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ivynnell Sandifer, MD 10145 N 107th St, Scottsdale, AZ 85258-6094 Ph: () - | Ivynnell Sandifer, MD Banner Baywood Medical Center, 6644 E. Baywood Ave, Mesa, AZ 85206 Ph: (480) 981-2000 |
News Archive
Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, was presented with the 2010 Arthur Steindler Award at this week's annual meeting of the Orthopaedic Research Society in New Orleans.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
The E484K mutation has also been found on the B.1.351 and P.1 variant, contributing to their status as variants of concern. In February 2021, Public Health England published a report of 11 B.1.1.7 genomes that also had the E484K spike mutation. Currently, there are 247 isolates of B.1.1.7 + E484K reported globally, and new research finds the first reports of it in southeastern Pennsylvania.
New research published in the December issue of The Journal of the American College of Surgeons shows that outcomes of high-risk cancer operations in 80-year-olds are considerably worse than reported in case studies and published survival statistics, which may lead to unrealistic expectations about the safety of these operations in the elderly.
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at Case Western Reserve University and Johns Hopkins Medical Institutions shows.
› Verified 9 days ago
Dr. Ramona Beatrice Woodriffe, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4824 E Baseline Rd, Suite 110, Mesa, AZ 85206 Phone: 480-969-4040 Fax: 480-830-1042 | |
David E. Boesch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 N Country Club Dr, Banner Mesa Medical Center, Mesa, AZ 85201 Phone: 480-834-1211 | |
Charles H Pshaenich, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-456-9500 Fax: 480-820-7623 | |
Richard Scholl, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 S Stapley Dr, Suite 101, Mesa, AZ 85204 Phone: 480-206-2424 | |
Joseph W Winchell, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-456-9500 Fax: 480-820-7623 | |
Diane L. Elmore, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 N Dobson Rd Ste 108, Mesa, AZ 85201 Phone: 480-456-9300 | |
Dr. Drummond Grant Vogan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4850 E Baseline Rd Ste 107, Mesa, AZ 85206 Phone: 480-908-9892 Fax: 602-661-1189 |